Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology has launched Invisalign Virtual Care AI, enhancing remote monitoring with AI-assisted features for orthodontists. This innovation allows doctors to manage patient treatment via the Invisalign Doctor Site without separate portals, streamlining workflows. Key functionalities include AI-assisted Automatic Assessment for tracking aligner fit and Automated Notifications to advise patients on their treatment progress. The system integrates with the Align Digital Platform, improving patient compliance and treatment tracking efficiency.
Align Technology has opened its first Europe, Middle East & Africa (EMEA) manufacturing facility in Wroclaw, Poland, marking a significant investment in the region. The new facility will support Align's EMEA operations and aims to produce almost 1 million clear aligner parts daily. This initiative is expected to create over 2,500 jobs by 2025. The facility aligns with Align's strategy to enhance service quality and delivery times for its customers, as the EMEA region contains over 7 million annual orthodontic cases and 150 million potential consumers.
Align Technology (NASDAQ: ALGN) reported Q2'22 revenues of $969.6 million, down 0.4% sequentially and 4.1% year-over-year. Clear Aligner sales decreased to $798.4 million, while Imaging Systems revenues rose 4.7% sequentially. The operating income was $188.2 million with a margin of 19.4%. Net income was $112.8 million, translating to $1.44 per diluted share. The company faced significant foreign exchange impacts, totaling approximately $15.3 million sequentially. Align purchased 757,000 shares at an average price of $264.37, demonstrating shareholder return strategy amidst economic challenges.
Align Technology, Inc. (NASDAQ: ALGN) will report its second quarter 2022 financial results on July 27, 2022, after market close at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET to discuss the results, accessible via audio webcast. The archived version will be available for one month. Align Technology specializes in the design, manufacture, and sales of clear aligners, intraoral scanners, and CAD/CAM software, providing solutions to enhance efficiency and patient outcomes in orthodontics.
BetterInvesting Magazine has highlighted Align Technology (ALGN) as its 'Stock to Study' and Qualcomm Inc. (QCOM) as its 'Undervalued Stock' in the September 2022 issue. This selection, made by the Editorial Advisory and Securities Review Committee, aims to provide investors with educational insights amid recent market conditions. Ken Zendel, CEO of NAIC, notes that the current market pullback offers opportunities for investors to acquire growth stocks at reasonable prices. The magazine encourages individuals to utilize BetterInvesting's tools for informed investment decisions.
Align Technology (Nasdaq: ALGN) has awarded $275,000 in research grants through its twelfth Annual Research Award Program, funding eleven projects at universities worldwide. The initiative aims to further research capabilities in digital orthodontics and clear aligner treatment. Recipients include institutions from the Americas, Europe, and Asia Pacific, focusing on various topics such as distalization and pre-surgical treatment for cleft palates. Align emphasizes the growing interest in advancing dental technologies through these grants.
Align Technology, Inc. (NASDAQ: ALGN) will present at the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 8:00 to 8:30 AM ET in New York, NY. The presentation will be webcast live on Align's Investor Relations website, with an archived replay available for approximately three months. This event will feature CEO Joe Hogan, CFO John Morici, and Corporate Communications Director Madelyn Valente. Align is known for its Invisalign system, iTero scanners, and exocad software, revolutionizing digital orthodontics and restorative dentistry for over 217,000 doctors and 12.8 million patients globally.
Align Technology announces a partnership with Asana to launch Asana Smiles™, a workflow solution tailored for Invisalign-trained doctors in the U.S. This platform allows dental practices to efficiently manage patients' treatment journeys, from consultations to aligner delivery. The solution is designed to integrate seamlessly with existing systems, enhancing practice efficiency and patient care. It will be showcased at the American Association of Orthodontists' Annual Session from May 21-24, 2022, and is set for release next month, with future expansion plans.
Align Technology has launched the Invisalign Outcome Simulator Pro, enhancing patient consultation through advanced visualization tools. Available on iTero Element Plus series scanners, it combines in-face simulations with 3D views of potential treatment outcomes, driving patient education and acceptance. This tool streamlines workflows and maximizes chair time for doctors, fostering efficiency. Dr. Johnathan Fitzpatrick emphasized its impact on treatment acceptance. The simulator will be featured at multiple upcoming conferences and is set for wider availability in the second half of 2022.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
